UCB enhances epilepsy portfolio with Zogenix acquisition
By acquiring Zogenix, UCB has obtained Fintepla, an approved drug for the treatment of seizures associated with Dravet syndrome.
By
GlobalData Healthcare
Latest articles
All Articles
Alexion to pay up to $760m for transthyretin amyloid cardiomyopathy drug
Alexion and Neurimmune will collaborate on NI006, a human monoclonal antibody developed for transthyretin amyloid cardiomyopathy.
By
Covid-19 update: Pfizer could have Omicron vaccine ready by March
Global: The global Covid death toll has passed 5.4 million, with a figure of 5,495,383 according to researchers at…
Covid-19 update: Strain of Covid-19 combining Delta and Omicron discovered
Global: The global Covid death toll has passed 5.4 million, with a figure of 5,488,750 according to researchers at…
Omicron wave disrupts wage growth hopes in Australia – leading macroeconomic influencers
Some economists believe that the Omicron wave will be a clear risk to pay rises this year, as increasing…
Pfizer and BioNTech continue partnership to develop new shingles vaccine
The collaboration to develop a shingles vaccine comes after the success of Pfizer and BioNTech’s Covid-19 vaccine.
By
Endometriosis market projected to grow at a CAGR of 10.6% between 2020 and 2030
The endometriosis sector across the seven major markets (7MM) is expected to grow from $1.06bn in 2020 to $2.91bn…
By
Endometriosis: how the market has developed and where it needs to be
There is a need for greater endometriosis awareness across the market, with the development of non-invasive diagnosis and more…
ByJohnson & Johnson’s Covid-19 vaccine problems continue
In 2021, the sales of J&J’s Covid-19 vaccine are forecast to be higher in the US than in the…
By